Our work here indicates that CS-E-mediated inhibition of the pro-tumorigenic Wnt/beta-catenin pathway in breast cancer cells provides one molecular mechanism by which chondroitin sulfates control Cola1a1 expression and alter a pro-tumorigenic breast cancer cell microenvironment. Here, CTNNB1 is linked to breast carcinoma.